HTAtlas
← Back to explore

One Wales Medicines Process

Methodvalidated

A process in Wales that allows patients to access certain medicines that haven't yet been formally assessed by national bodies, under special conditions while awaiting a full review.

At a glance

Use when

A medicine is not yet assessed by NICE or AWMSG but is urgently needed for a patient group in Wales

Avoid when

The medicine has already been appraised by NICE or AWMSG, or when robust evidence is lacking

Inputs

Medicine not appraised by NICE or AWMSG, clinical need justification, interim commissioning request

Outputs

Conditional patient access to medicine, structured assessment by OWMAG/LOWMAG, requirement for future formal appraisal

How it works

An interim-commissioning framework managed by AWTTC and the Welsh Government, enabling conditional access to medicines not appraised by NICE or AWMSG through the One Wales Medicines Assessment Groups (OWMAG/LOWMAG), pending formal evaluation.

HTA domains
Costs & Economic Evaluation, Organisational aspects, Patient and Social Aspects
Assumptions
There is a significant clinical need; the medicine shows potential benefit; formal appraisal will follow
Strengths
Enables timely patient access to promising treatments; structured oversight via expert groups; aligns with future formal assessment
Limitations
Access is conditional and time-limited; dependent on subsequent appraisal outcomes; may not guarantee long-term funding
Also known as
One Wales, OWMAG, LOWMAG, Licensed One Wales Medicines Assessment Groups

Questions this answers

References & sources

Similar by meaning

Beta record. Based on the original catalogue summary; primary-source enrichment pending.